The 8 references in paper N. Geppe A., N. Kolosova G., Н. Геппе А., Н. Колосова Г. (2014) “Безопасность и эффективность – основа выбора ингаляционных глюкокортикостероидов в терапии бронхиальной астмы у детей // Safety and efficacy as fundamental choice of inhaled steroids for treatment of childhood asthma” / spz:neicon:pulmonology:y:2013:i:1:p:86-89

1
National Asthma Education and Prevention Program. Expert Panel Report 3 (EPR$3): Guidelines for the diagno$ sis and management of asthma$summary report 2007. J. Allergy Clin. Immunol. 2007; 120 (5, Suppl.): 94–138.
(check this in PDF content)
2
Asperen P.P., Mellis C.M., Sly P.D. Thoracic Society of Australia and New Zealand. The role of corticosteroids in the management of childhood asthma. Med. J. Aust. 2002; 176 (4): 168–173.
(check this in PDF content)
3
Национальная программа "Бронхиальная астма у де$ тей. Стратегия лечения и профилактика". 4$е изд. М.; 2012.
(check this in PDF content)
4
Leung D.Y.M., Bloom J.W. Update on glucocorticoid action and resistance. J. Allergy Clin. Immunol. 2003; 111: 3–22.
(check this in PDF content)
5
Malmstrom K., Rodriguez2Gomez G., Guerra J. et al.Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. Ann. Intern. Med. 1999; 130: 487–495.
(check this in PDF content)
6
Szefler S.J., Martin R.J., King T.S. et al. Significant variabil$ ity in response to inhaled corticosteroids for persistent asth$ ma. J. Allergy Clin. Immunol. 2002; 109: 410–418.
(check this in PDF content)
7
Lipworth B.J. Systemic adverse effects of inhaled corticos$ teroid therapy. A systematic review and meta$analysis. Arch. Intern. Med. 1999; 159: 941–955.
(check this in PDF content)
8
Sont J.K., Willems L.N.A., Bel E.H. et al.Clinical control and histopathologic outcome of asthma when using airway http:// www.pulmonology.ru89
(check this in PDF content)